<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Streptococcus agalactiae Serotype Distribution and Antimicrobial Susceptibility in Pregnant Women in Gabon, Central Africa</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-11-25">25 November 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Sabine</forename><surname>Belard</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Centre de Recherches Médicales de Lambaréné</orgName>
								<orgName type="institution">Hôpital Albert Schweitzer</orgName>
								<address>
									<settlement>Lambaréné</settlement>
									<country key="GA">Gabon</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Institut für Tropenmedizin</orgName>
								<orgName type="institution">Universität Tübingen</orgName>
								<address>
									<settlement>Tübingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Pediatric Pneumology and Immunology</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nicole</forename><surname>Toepfner</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Clinic and Polyclinic for Pediatrics and Adolescent Medicine</orgName>
								<orgName type="institution" key="instit1">University Hospital Carl Gustav Carus</orgName>
								<orgName type="institution" key="instit2">Technische Universität Dresden</orgName>
								<address>
									<settlement>Dresden</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mesküre</forename><surname>Capan-Melser</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Centre de Recherches Médicales de Lambaréné</orgName>
								<orgName type="institution">Hôpital Albert Schweitzer</orgName>
								<address>
									<settlement>Lambaréné</settlement>
									<country key="GA">Gabon</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Institut für Tropenmedizin</orgName>
								<orgName type="institution">Universität Tübingen</orgName>
								<address>
									<settlement>Tübingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Department of Medicine I</orgName>
								<orgName type="department" key="dep2">Division of Infectious Diseases and Tropical Medicine</orgName>
								<orgName type="institution">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ghyslain</forename><surname>Mombo- Ngoma</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Rella</forename><surname>Zoleko-Manego</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Centre de Recherches Médicales de Lambaréné</orgName>
								<orgName type="institution">Hôpital Albert Schweitzer</orgName>
								<address>
									<settlement>Lambaréné</settlement>
									<country key="GA">Gabon</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Institut für Tropenmedizin</orgName>
								<orgName type="institution">Universität Tübingen</orgName>
								<address>
									<settlement>Tübingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Département de Parasitologie</orgName>
								<orgName type="institution">Université des Sciences de la Santé</orgName>
								<address>
									<settlement>Libreville</settlement>
									<country key="GA">Gabon</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="institution">Ngounie Medical Research Centre</orgName>
								<address>
									<settlement>Fougamou</settlement>
									<country key="GA">Gabon</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mirjam</forename><surname>Groger</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Centre de Recherches Médicales de Lambaréné</orgName>
								<orgName type="institution">Hôpital Albert Schweitzer</orgName>
								<address>
									<settlement>Lambaréné</settlement>
									<country key="GA">Gabon</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Institut für Tropenmedizin</orgName>
								<orgName type="institution">Universität Tübingen</orgName>
								<address>
									<settlement>Tübingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Department of Medicine I</orgName>
								<orgName type="department" key="dep2">Division of Infectious Diseases and Tropical Medicine</orgName>
								<orgName type="institution">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Pierre-Blaise</forename><surname>Matsiegui</surname></persName>
							<affiliation key="aff6">
								<orgName type="institution">Ngounie Medical Research Centre</orgName>
								<address>
									<settlement>Fougamou</settlement>
									<country key="GA">Gabon</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Selidji</forename><forename type="middle">T</forename><surname>Agnandji</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Centre de Recherches Médicales de Lambaréné</orgName>
								<orgName type="institution">Hôpital Albert Schweitzer</orgName>
								<address>
									<settlement>Lambaréné</settlement>
									<country key="GA">Gabon</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Institut für Tropenmedizin</orgName>
								<orgName type="institution">Universität Tübingen</orgName>
								<address>
									<settlement>Tübingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ayôla</forename><forename type="middle">A</forename><surname>Adegnika</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Centre de Recherches Médicales de Lambaréné</orgName>
								<orgName type="institution">Hôpital Albert Schweitzer</orgName>
								<address>
									<settlement>Lambaréné</settlement>
									<country key="GA">Gabon</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Institut für Tropenmedizin</orgName>
								<orgName type="institution">Universität Tübingen</orgName>
								<address>
									<settlement>Tübingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Raquel</forename><surname>González</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Barcelona Ctr. Int. Health Res (CRESIB)</orgName>
								<orgName type="institution" key="instit1">ISGlobal</orgName>
								<orgName type="institution" key="instit2">Hospital Clínic-Universitat de Barcelona)</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><forename type="middle">G</forename><surname>Kremsner</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Centre de Recherches Médicales de Lambaréné</orgName>
								<orgName type="institution">Hôpital Albert Schweitzer</orgName>
								<address>
									<settlement>Lambaréné</settlement>
									<country key="GA">Gabon</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Institut für Tropenmedizin</orgName>
								<orgName type="institution">Universität Tübingen</orgName>
								<address>
									<settlement>Tübingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Clara</forename><surname>Menendez</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Barcelona Ctr. Int. Health Res (CRESIB)</orgName>
								<orgName type="institution" key="instit1">ISGlobal</orgName>
								<orgName type="institution" key="instit2">Hospital Clínic-Universitat de Barcelona)</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Michael</forename><surname>Ramharter</surname></persName>
							<email>michael.ramharter@medizin-uni-tuebingen.de</email>
							<affiliation key="aff0">
								<orgName type="laboratory">Centre de Recherches Médicales de Lambaréné</orgName>
								<orgName type="institution">Hôpital Albert Schweitzer</orgName>
								<address>
									<settlement>Lambaréné</settlement>
									<country key="GA">Gabon</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Institut für Tropenmedizin</orgName>
								<orgName type="institution">Universität Tübingen</orgName>
								<address>
									<settlement>Tübingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Department of Medicine I</orgName>
								<orgName type="department" key="dep2">Division of Infectious Diseases and Tropical Medicine</orgName>
								<orgName type="institution">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Reinhard</forename><surname>Berner</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Clinic and Polyclinic for Pediatrics and Adolescent Medicine</orgName>
								<orgName type="institution" key="instit1">University Hospital Carl Gustav Carus</orgName>
								<orgName type="institution" key="instit2">Technische Universität Dresden</orgName>
								<address>
									<settlement>Dresden</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Streptococcus agalactiae Serotype Distribution and Antimicrobial Susceptibility in Pregnant Women in Gabon, Central Africa</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-11-25">25 November 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">26AB4EBC5F825A279395EF4C517AA934</idno>
					<idno type="DOI">10.1038/srep17281</idno>
					<note type="submission">Received: 02 June 2015 Accepted: 28 September 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:27+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Neonatal invasive disease due to Streptococcus agalactiae is life threatening and preventive strategies suitable for resource limited settings are urgently needed.</s><s>Protective coverage of vaccine candidates based on capsular epitopes will relate to local epidemiology of S. agalactiae serotypes and successful management of critical infections depends on timely therapy with effective antibiotics.</s><s>This is the first report on serotype distribution and antimicrobial susceptibility of S. agalactiae in pregnant women from a Central African region.</s><s>Serotypes V, III, and Ib accounted for 88/109 (81%) serotypes and all isolates were susceptible to penicillin and clindamycin while 13% showed intermediate susceptibility to erythromycin.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Neonatal invasive disease due to Streptococcus agalactiae is a life threatening infection.</s><s>In industrialized countries prenatal screening in pregnant women and intra-partum antibiotic prophylaxis (IAP) have been widely established and successfully reduced the incidence of newborn morbidity and mortality related to S. agalactiae <ref type="bibr">1,</ref><ref type="bibr" target="#b0">2</ref> .</s><s>In low income settings recto-vaginal colonization rates with S. agalactiae in pregnant women are similar <ref type="bibr" target="#b1">3</ref> ; however, screening and IAP for prevention of invasive neonatal disease is mostly not implemented due to limitations in resources and infrastructure.</s><s>Vaccination of pregnant women is an alternative prevention strategy that proved effective for other neonatal infectious diseases (i.e.</s><s>neonatal tetanus), and several S. agalactiae vaccine candidates are currently in pre-clinical and clinical development <ref type="bibr" target="#b2">4</ref> .</s><s>Ten capsular polysaccharides have been identified as important virulence factors of S. agalactiae and differentiate S. agalactiae into ten distinct serotypes.</s><s>Based on serotype pathogenicity and prevalence, a trivalent polysaccharide-protein conjugate vaccine composed of capsular epitopes from serotypes Ia, Ib and III is in Phase II evaluation (NCT02046148); protective coverage will depend on selected S. agalactiae serotypes and S. agalactiae serotype distribution in target populations.</s><s>In case of critical infections due to S. agalactiae effective management will depend on timely therapy with antibiotics to which S. agalactiae is sensitive.</s><s>There is a lack of knowledge on the epidemiology of S. agalactiae in pregnant women from Central sub-Saharan Africa.</s><s>The aim of this study was to describe serotype distribution and antimicrobial susceptibility of S. agalactiae in pregnant women from Gabon.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p><s>Serotypes and antibiotic susceptibility of S. agalactiae isolates from HIV-negative pregnant women participating in a multicentre randomized controlled clinical trial comparing the safety and efficacy of mefloquine and sulfadoxine-pyrimethamine for intermittent preventive treatment for malaria in pregnancy (IPTp) in Gabon (MIPPAD trial; NCT 00811421, registration date December 18, 2008) were studied.</s><s>Detailed information on study design, methods, clinical data and outcomes has been published recently <ref type="bibr" target="#b3">5,</ref><ref type="bibr" target="#b4">6</ref> ; the study protocol was approved by the CERMEL institutional ethics review board and all experiments were carried out in accordance with international regulations including the Declaration of Helsinki .</s><s>In summary, recto-vaginal swabs were taken at presentation for delivery; nylon flocked swabs were used and submerged into Amies transport medium; Lim Broth was inoculated, incubated at 37 °C and then sub-cultured on Granada agar under aerobic conditions at 37 °C for 24 h; yellow-orange pigmented colonies on Granada agar confirmed growth of S. agalactiae.</s><s>After storage at − 20 °Celsius isolates were re-cultured on 5% sheep blood agar and serotypes of the capsular polysaccharides Ia, Ib, II-IX were determined by latex agglutination (Strep-B-latex kit; Article 54991/Lot La-1-4, Statens Serum Institute, Denmark) according to the manufacturer's instructions.</s><s>Isolates were additionally confirmed by S. agalactiae multiplex PCR as described by Creti et al. <ref type="bibr" target="#b5">7</ref> .</s><s>Antibiotic drug susceptibility testing was performed on horse blood agar plates (MHF, BioMérieux ® ).</s><s>Disc diffusion test was performed with erythromycin (15 μ g), clindamycin (2 μ g), cefotaxim (30 μ g), vancomycin (5 μ g), and linezolid (10 μ g).</s></p><p><s>gMIC determination was performed as E-Test (BioMérieux ® ) for benzylpenicillin, cefalotin, cefotaxim and gentamicin; isolates were screened for the presence of high-level gentamicin resistance (HLGR, MIC &gt; 500 mg/L).</s><s>Isolates with intermediate susceptibility to erythromycin were investigated for inducible clindamycin resistance by double disc diffusion test (DDT).</s><s>Disc diffusion tests and gMIC determination were performed and interpreted according to the EUCAST (www.eucast.org)</s><s>guidelines.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results and Discussion</head><p><s>The prevalence of maternal S. agalactiae colonization at delivery has been reported by Capan-Melser et al. and was 19% (106/549; 95% CI 16-23%); S. agalactiae colonization was unrelated to IPTp and illiteracy was the only factor associated with higher colonization rates <ref type="bibr" target="#b3">5</ref> .</s><s>One hundred and nine S. agalactiae isolates were available for serotyping and antibiotic resistance testing.</s><s>Serotyping by latex agglutination test and PCR was congruent and there was no non-typeable isolate.</s><s>Almost a third (33/109, 30.3%) of isolates were serotype V; second most prevalent was serotype III (30/109, 27.5%), followed by serotype Ib (25/109, 22.9%), serotype Ia (14/109, 12.8%), and serotype II (7/109, 6.4%) (Table <ref type="table">1</ref>).</s><s>No serotypes IV, VI, VII, XIII or XI were identified.</s></p><p><s>Serotype distribution varies between countries.</s><s>Serotype V as most common serotype has been reported from The Gambia 8 and Egypt 9 as well, while in South Africa and Morocco serotypes Ia and III dominated with around 30-40% and serotype V represented only around 10% of isolates <ref type="bibr" target="#b8">[10]</ref><ref type="bibr" target="#b9">[11]</ref><ref type="bibr" target="#b10">[12]</ref> .</s><s>Two studies from Zimbabwe found serotypes III, V and Ia to be the most prevalent serotypes in decreasing order <ref type="bibr" target="#b11">13,</ref><ref type="bibr" target="#b12">14</ref> .</s><s>Importantly, one study from South Africa did not find significant differences in serotype distribution between vaginal and newborn colonizing isolates, but serotype distribution of invasive S. agalactiae isolates were significantly different to that of colonizing isolates <ref type="bibr" target="#b9">11</ref> .</s><s>Therefore, in the light of development of serotype-based vaccines, studies on invasive isolates are crucial.</s><s>In a systematic review and meta-analysis on S. agalactiae disease in infants aged &lt; 3 months no low-income country was represented in the serotype assessment due to lack of data; the most frequently identified serotype in all regions with available data was serotype III (48.9%) followed by serotypes Ia (22.9%),</s><s>Ib (7.0%), II (6.2%), and V (9.1%), and five serotypes (Ia, Ib, II, III, V) accounted for &gt; 85% of all serotypes <ref type="bibr" target="#b13">15</ref> .</s><s>Limited data on molecular characteristics of African GBS isolates suggests that the overall population structure is similar to industrialized countries <ref type="bibr" target="#b14">[16]</ref><ref type="bibr" target="#b15">[17]</ref><ref type="bibr" target="#b16">[18]</ref> .</s></p><p><s>In this study, by disc diffusion test evaluation, all isolates were susceptible to clindamycin, cefotaxim, linezolid and vancomycin.</s><s>Fourteen (13%) isolates showed intermediate susceptibility to erythromycin (Table <ref type="table" target="#tab_0">2</ref>); for these isolates no inducible clindamycin resistance was found by DDT.</s><s>By E-test, no resistance to benzylpenicilline, cefotaxim, and cefalotin, and no high level gentamicin resistance were Table <ref type="table">1</ref>.</s><s>Serotype distribution of S. agalactiae isolates.</s></p><p><s>observed (Table <ref type="table" target="#tab_0">2</ref>).</s><s>Whereas various studies in Asia, Europe and the United States have found a significant association between serotype V and macrolide resistance, it is remarkable that this association was not found in our cohort (Fisher's Exact Test).</s><s>S. agalactiae has been regarded universally susceptible to penicillins and these are the antibiotics of first choice for the treatment of S. agalactiae infections.</s><s>Data of this study confirm susceptibility of S. agalactiae to penicillins also for this setting; however, evidence of S. agalactiae with reduced penicillin susceptibility and additional resistance to other antibiotic drug classes is increasing <ref type="bibr" target="#b17">[19]</ref><ref type="bibr" target="#b18">[20]</ref><ref type="bibr" target="#b19">[21]</ref> and also reported from the African continent <ref type="bibr" target="#b20">22,</ref><ref type="bibr" target="#b21">23</ref> underlining the importance of continuous surveillance to guide empiric treatment.</s><s>Erythromycin is commonly used in case of allergy to penicillins but varying rates of erythromycin resistance are reported by most studies evaluating its susceptibility.</s><s>In this study intermediate susceptibility for erythromycin was seen in 13%, a rate that has also been reported for other sub-Saharan African settings <ref type="bibr" target="#b20">22,</ref><ref type="bibr" target="#b21">23</ref> .</s><s>As all isolates were susceptible to clindamycin in this study; clindamycin may therefore be a more suitable second-line antibiotic for S. agalactiae infections than erythromycin in this setting.</s><s>The absence of high level gentamicin resistance supports the recommendation that neonates with suspicion of sepsis or meningitis should be treated with the combination of ampicillin and gentamicin.</s></p><p><s>In conclusion, S. agalactiae isolates colonizing pregnant women in Gabon showed a serotype distribution in line with other reports from Africa and a susceptibility profile suggesting penicillins as first-line and clindamycin as alternative antibiotic for infections due to S. agalactiae.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Antimicrobial susceptibility of S. agalactiae isolates (Total n = 109 isolates).</s><s>MIC: minimum inhibitory concentration, HLGR: high level gentamicin resistance.</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell>Sensitive n</cell><cell>Intermediate</cell><cell>Resistant n</cell><cell></cell></row><row><cell>Antibiotic Agent</cell><cell>Interpretation</cell><cell>(%)</cell><cell>n (%)</cell><cell>(%)</cell><cell>MIC Range (MIC50)</cell></row><row><cell>E-Test</cell><cell>(MIC (mg/L))</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Benzylpenicillin</cell><cell>S &gt; 0.25, R &lt; 0.25</cell><cell>109 (100)</cell><cell>0</cell><cell>0</cell><cell>0,016;0,19 (0.064)</cell></row><row><cell>Cefalotin</cell><cell>S &gt; 0.25, R &lt; 0.25</cell><cell>109 (100)</cell><cell>0</cell><cell>0</cell><cell>0.032;019 (0.125)</cell></row><row><cell>Cefotaxim</cell><cell>S &gt; 0.25, R &lt; 0.25</cell><cell>109 (100)</cell><cell>0</cell><cell>0</cell><cell>&lt; 0.016;0.064 (0.047)</cell></row><row><cell>Gentamicin</cell><cell>HLGR &gt; 500mg/l</cell><cell>No HLGR</cell><cell></cell><cell></cell><cell>2;256 (48)</cell></row><row><cell>Disc diffusion test</cell><cell>(Zone diameter (mm))</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Erythromycin (15μ g)</cell><cell>S &gt; 21, I 18-20, R ≤ 17</cell><cell>95 (87.2)</cell><cell>14 (12.8)</cell><cell>0</cell><cell>-</cell></row><row><cell>Vancomycin (5μ g)</cell><cell>S &gt; 13, R &lt; 13</cell><cell>109 (100)</cell><cell>NA</cell><cell>0</cell><cell>-</cell></row><row><cell>Linezolid (10μ g)</cell><cell>S &gt; 19, I 16-18, R &lt; 15</cell><cell>109 (100)</cell><cell>0</cell><cell>0</cell><cell>-</cell></row><row><cell>Clindamycin (2μ g)</cell><cell>S &gt; 17, R &lt; 17</cell><cell>109 (100)</cell><cell>NA</cell><cell>0</cell><cell>-</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Scientific RepoRts | 5:17281 | DOI: 10.1038/srep17281</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>This work was part of a clinical trial (MIPPAD) supported by EDCTP (EDCTPIP.07.31080.002),</s><s>BMBF (FKZ 01KA0803) and the Malaria in Pregnancy Consortium, which is funded through a grant from the Bill and Melinda Gates Foundation to the Liverpool School of Tropical Medicine and the Federal Ministry of Education and Research (BMBF FKZ: da01KA0803), Germany.</s><s>SB is a participant in the Charité Clinical Scientist Program founded by the Charité -Universitätsmedizin Berlin and the Berlin Institute of Health.</s><s>We thank all pregnant women for their willingness to participate in this study.</s><s>We are grateful to Uta Falke for her support in the laboratory.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author Contributions</head> <ref type="table">1 and 2</ref><p><s>. All authors reviewed the manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Additional Information</head><p><s>Competing financial interests: The authors declare no competing financial interests.</s><s>This work is licensed under a Creative Commons Attribution 4.0 International License.</s><s>The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material.</s><s>To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>How to cite this article</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Trends in the epidemiology of neonatal sepsis of vertical transmission in the era of group B streptococcal prevention</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Lopez Sastre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Fernandez Colomer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Coto Cotallo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ramos Aparicio</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Paediatr</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">451</biblScope>
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Epidemiology and management of group B streptococcal colonization during pregnancy in Africa</title>
		<author>
			<persName><forename type="first">M</forename><surname>Capan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Wien Klin Wochenschr</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page">14</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">A maternal vaccine against group B streptococcus: past, present, and future</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">L</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">Y</forename><surname>Avci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Kasper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Vaccine</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page">D13</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Evaluation of intermittent preventive treatment of malaria against group B streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine</title>
		<author>
			<persName><forename type="first">M</forename><surname>Capan-Melser</surname></persName>
		</author>
		<idno>pii: dkv041</idno>
	</analytic>
	<monogr>
		<title level="j">J Antimicrob Chemother</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial</title>
		<author>
			<persName><forename type="first">R</forename><surname>Gonzalez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Med</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">e1001733</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Multiplex PCR assay for direct identification of group B streptococcal alpha-protein-like protein genes</title>
		<author>
			<persName><forename type="first">R</forename><surname>Creti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fabretti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Orefici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Von Hunolstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">1326</biblScope>
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Carriage of group B streptococci in pregnant Gambian mothers and their infants</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">O</forename><surname>Suara</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">170</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">1316</biblScope>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Serotype and surface protein gene distribution of colonizing group B streptococcus in women in Egypt</title>
		<author>
			<persName><forename type="first">S</forename><surname>Shabayek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Abdalla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Abouzeid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Epidemiol Infect</title>
		<imprint>
			<biblScope unit="volume">142</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">208</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Serotype-specific acquisition and loss of group B streptococcus recto-vaginal colonization in late pregnancy</title>
		<author>
			<persName><forename type="first">G</forename><surname>Kwatra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">e98778</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads</title>
		<author>
			<persName><forename type="first">M</forename><surname>Madzivhandila</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">e17861</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Serotypes and antimicrobial susceptibility of group B streptococcus isolated from neonates in Casablanca</title>
		<author>
			<persName><forename type="first">R</forename><surname>Aitmhand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Moustaoui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Belabbes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Elmdaghri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Benbachir</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scand J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">339</biblScope>
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">capsular type distribution, anthropometric and obstetric factors of group B streptococcus (Streptococcus agalactiae) colonization in pregnancy</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Moyo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mudzori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Tswana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Maeland</surname></persName>
		</author>
		<author>
			<persName><surname>Prevalence</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cent Afr J Med</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">115</biblScope>
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Serotype markers in a Streptococcus agalactiae strain collection from Zimbabwe</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Mavenyengwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Maeland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Moyo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Indian J Med Microbiol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">313</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Edmond</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">379</biblScope>
			<biblScope unit="issue">9815</biblScope>
			<biblScope unit="page">547</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Population structure of human isolates of Streptococcus agalactiae from Dakar and Bangui</title>
		<author>
			<persName><forename type="first">M</forename><surname>Brochet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Couve</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bercion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Sire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Glaser</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">800</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Molecular epidemiology of group B streptococcal meningitis in children beyond the neonatal period from Angola</title>
		<author>
			<persName><forename type="first">C</forename><surname>Florindo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Med Microbiol</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page">1276</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>Pt 9</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Characterization of invasive and colonizing isolates of Streptococcus agalactiae in East African adults</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Huber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mcodimba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Pflueger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Daubenberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Revathi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page">3652</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Andrews</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">859</biblScope>
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">High frequency of fluoroquinolone-and macrolide-resistant streptococci among clinically isolated group B streptococci with reduced penicillin susceptibility</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kimura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Antimicrob Chemother</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">539</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiae in a Latin American hospital: a 17-year study</title>
		<author>
			<persName><forename type="first">P</forename><surname>Crespo-Ortiz Mdel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Castaneda-Ramirez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Recalde-Bolanos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Velez-Londono</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Infect Dis</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">428</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Susceptibility of Zimbabwean Streptococcus agalactiae (group B streptococcus; GBS) isolates to four different antibiotics</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Moyo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Maeland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Munemo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cent Afr J Med</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">226</biblScope>
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Maternal and neonatal colonisation of group B streptococcus at Muhimbili National Hospital in Dar es Salaam, Tanzania: prevalence, risk factors and antimicrobial resistance</title>
		<author>
			<persName><forename type="first">A</forename><surname>Joachim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Matee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Massawe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Lyamuya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Public Health</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">437</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
